MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejphar.2026.178734

Медицинская библиотека · European journal of pharmacology · 2026

Ursolic acid attenuates bone loss by stabilizing osteoblast mitochondrial integrity and inhibiting downstream apoptosis via PI3K-AKT-Bcl2 signaling.

Wang Jili, Li Xiaoyu, Cai Qingzhi, Zheng Yongzhi, Chai Shuang, Li Xun, Dong Xiaokun, Yuan Bingsen, Wang Shangzeng, Wan Lei

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The PI3K/AKT signaling pathway is crucial in mitochondrial apoptosis and a core mechanism in the pathogenesis of osteoporosis (OP). Ursolic acid (UA) is a naturally occurring pentacyclic triterpenoid found in various herbal plants that exhibits antioxidant and anti-inflammatory activities and modulates osteoblast function. However, the effects of UA on osteoblast function in OP remain unclear. This study investigated whether UA alleviates mitochondrial damage, inhibits downstream apoptosis, and promotes osteoblast differentiation via the PI3K-AKT pathway.

METHODS

Network pharmacology and molecular docking were used to predict the anti-OP mechanisms of UA. The regulatory effects of UA on the PI3K-AKT axis were evaluated in MC3T3-E1 cells, while its impact on mitochondrial function and osteoblast differentiation was assessed in the presence of LY294002 (PI3K inhibitor) or ABT-737 (Bcl2 inhibitor). The OP mouse model was established via ovariectomy (OVX). Mice received UA (10 or 20 mg/kg/day) or estradiol (0.104 mg/kg/day) as a positive control. Bone microstructure, apoptosis, mitochondrial integrity, and bone metabolism markers were examined.

RESULTS

UA promoted osteoblast differentiation. Network pharmacology and docking identified the PI3K-AKT pathway as a key UA target, which was subsequently validated in vitro. UA mitigated LY294002- or ABT-737-induced mitochondrial damage, alleviated mitochondrial oxidative stress, stabilized mitochondrial membrane potential, and further enhanced osteoblast differentiation. Furthermore, UA attenuated OVX-induced bone loss by restoring PI3K-AKT activity, upregulating Bcl2, improving mitochondrial function, and inhibiting apoptosis.

CONCLUSION

UA promotes osteoblast differentiation and mitigates mitochondrial dysfunction by activating PI3K-AKT-Bcl2 signaling. The findings provide evidence supporting UA as a potential therapeutic candidate for OP.

Для цитирования: Wang Jili, Li Xiaoyu, Cai Qingzhi, Zheng Yongzhi, Chai Shuang, Li Xun, Dong Xiaokun, Yuan Bingsen, Wang Shangzeng, Wan Lei. Ursolic acid attenuates bone loss by stabilizing osteoblast mitochondrial integrity and inhibiting downstream apoptosis via PI3K-AKT-Bcl2 signaling.. European journal of pharmacology. 2026. DOI: 10.1016/j.ejphar.2026.178734.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.